Testicular cancer: The quest continues

Patrick Loehrer, Stephen D. Williams, Lawrence Einhorn

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Treatment for testicular cancer has dramatically improved during the last 15 years. Much of this success has come about because of improved staging and operative techniques but, most importantly, through the introduction of successful systemic chemotherapy. Nonetheless, relevant issues still remain to be addressed in regard to the optimal therapy for patients with germ cell neoplasms. Included in these issues is delineating the most effective but minimally morbid treatment for patients with early-stage and low-volume metastatic disease while continuing to create innovative treatment approaches for poor-risk patients with metastatic disease. The unique association of primary mediastinal germ cell neoplasms with the development of non-germ cell cancers and Klinefelter's syndrome may provide some early clues for the determination of factors controlling differentiation. These observations issue a challenge to both clinical and preclinical researchers involved in the study of this neoplasm. [J Natl Cancer Inst 1988;80:1373-1382].

Original languageEnglish
Pages (from-to)1373-1382
Number of pages10
JournalJournal of the National Cancer Institute
Volume80
Issue number17
DOIs
StatePublished - Feb 2 1988

Fingerprint

Testicular Neoplasms
Cancer
Continue
Cells
Germ Cell and Embryonal Neoplasms
Cell
Mediastinal Neoplasms
Chemotherapy
Klinefelter Syndrome
Neoplasms
Therapy
Therapeutics
Research Personnel
Drug Therapy

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging
  • Oncology
  • Cancer Research

Cite this

Testicular cancer : The quest continues. / Loehrer, Patrick; Williams, Stephen D.; Einhorn, Lawrence.

In: Journal of the National Cancer Institute, Vol. 80, No. 17, 02.02.1988, p. 1373-1382.

Research output: Contribution to journalArticle

@article{e28d514c30464995a0c473b86e37e800,
title = "Testicular cancer: The quest continues",
abstract = "Treatment for testicular cancer has dramatically improved during the last 15 years. Much of this success has come about because of improved staging and operative techniques but, most importantly, through the introduction of successful systemic chemotherapy. Nonetheless, relevant issues still remain to be addressed in regard to the optimal therapy for patients with germ cell neoplasms. Included in these issues is delineating the most effective but minimally morbid treatment for patients with early-stage and low-volume metastatic disease while continuing to create innovative treatment approaches for poor-risk patients with metastatic disease. The unique association of primary mediastinal germ cell neoplasms with the development of non-germ cell cancers and Klinefelter's syndrome may provide some early clues for the determination of factors controlling differentiation. These observations issue a challenge to both clinical and preclinical researchers involved in the study of this neoplasm. [J Natl Cancer Inst 1988;80:1373-1382].",
author = "Patrick Loehrer and Williams, {Stephen D.} and Lawrence Einhorn",
year = "1988",
month = "2",
day = "2",
doi = "10.1093/jnci/80.17.1373",
language = "English",
volume = "80",
pages = "1373--1382",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Testicular cancer

T2 - The quest continues

AU - Loehrer, Patrick

AU - Williams, Stephen D.

AU - Einhorn, Lawrence

PY - 1988/2/2

Y1 - 1988/2/2

N2 - Treatment for testicular cancer has dramatically improved during the last 15 years. Much of this success has come about because of improved staging and operative techniques but, most importantly, through the introduction of successful systemic chemotherapy. Nonetheless, relevant issues still remain to be addressed in regard to the optimal therapy for patients with germ cell neoplasms. Included in these issues is delineating the most effective but minimally morbid treatment for patients with early-stage and low-volume metastatic disease while continuing to create innovative treatment approaches for poor-risk patients with metastatic disease. The unique association of primary mediastinal germ cell neoplasms with the development of non-germ cell cancers and Klinefelter's syndrome may provide some early clues for the determination of factors controlling differentiation. These observations issue a challenge to both clinical and preclinical researchers involved in the study of this neoplasm. [J Natl Cancer Inst 1988;80:1373-1382].

AB - Treatment for testicular cancer has dramatically improved during the last 15 years. Much of this success has come about because of improved staging and operative techniques but, most importantly, through the introduction of successful systemic chemotherapy. Nonetheless, relevant issues still remain to be addressed in regard to the optimal therapy for patients with germ cell neoplasms. Included in these issues is delineating the most effective but minimally morbid treatment for patients with early-stage and low-volume metastatic disease while continuing to create innovative treatment approaches for poor-risk patients with metastatic disease. The unique association of primary mediastinal germ cell neoplasms with the development of non-germ cell cancers and Klinefelter's syndrome may provide some early clues for the determination of factors controlling differentiation. These observations issue a challenge to both clinical and preclinical researchers involved in the study of this neoplasm. [J Natl Cancer Inst 1988;80:1373-1382].

UR - http://www.scopus.com/inward/record.url?scp=0023691178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023691178&partnerID=8YFLogxK

U2 - 10.1093/jnci/80.17.1373

DO - 10.1093/jnci/80.17.1373

M3 - Article

C2 - 3050140

AN - SCOPUS:0023691178

VL - 80

SP - 1373

EP - 1382

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 17

ER -